$0.73
+0.01 (+0.90%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,962.6% upside
Low Target
$11.92
Average Target
$15.08
High Target
$19.61
Current Price
$0.73
Current
$0.73
$0.73
Target
$15.08
$15.08
$11.92
$15.08 avg
$19.61
Scenario Analysis
Bear Case
$11.92
1,530.4%
Low target
Base Case
$15.08
+1,962.6%
Avg target
Bull Case
$19.61
+2,582.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$3.15
-76.8% from high
52-Week Low
$0.68
+7.8% from low
Target vs 52W High
$15.08
+378.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |